. 2021 Mar;13(3):1671–1683. doi: 10.21037/jtd-20-2233

Table 2. Preoperative patient characteristics [unmatched].

Study	Year	Approach	n	Age [years]	Female [%]	CVA [%]	COPD [%]	HTN [%]	PVD [%]	DM [%]	PAH [%]	EF %	NYHA III/IV [%]	Euroscore
RT
Nguyen	2017	MiAVR	699	72.4±11.1	267 [39]	NR	NR	607 [87]	88 [13]	219 [31]	NR	57.7±10	NR	NR
Nguyen	2017	TAVI	1,030	79.8±9.5	426 [41]	NR	NR	985 [96]	335 [33]	458 [45]	NR	51.3±14	NR	NR
Micelli	2016	MiAVR	178	76.1±6.7	118 [66]	NR	32 [18]	151 [85]	32 [18]	43 [24]	22 [12]	57.7±9	52 [29]	10.2±7.8^#
Micelli	2016	TAVI	91	79.5±6.4	46 [51]	NR	31 [34]	78 [86]	31 [34]	21 [23]	15 [17]	50±10	58 [64]	22.4±14.7^#
Tokarek	2015	MiAVR	50	63±4.8	33 [66]	NR	NR	NR	NR	NR	NR	NR	16 [32]	1.0±0.2*
Tokarek	2015	TAVI^a	39	80±2.5	14 [36]	NR	NR	NR	NR	NR	NR	NR	29 [74]	3.4±0.9*
HS
Furu-kawa	2018	MiAVR	1,929	70±11.1	836 [43]	37 [2]	88 [5]	1,447 [75]	60 [3]	362 [19]	177 [9]	60±7	727 [38]	1.3±0.82*
Furu-kawa	2018	TAVI	1,880	82.7±5.4	1,065 [57]	126 [7]	261 [14]	1,680 [89]	320 [17]	601 [32]	764 [41]	55±9	1371 [73]	5.7±4.2*
Calle-Verda	2018	MiAVR	50	82.3±4.8	22 [44]	5 [10]	7 [14]	41 [82]	6 [12]	11 [22]	NR	NR	24 [48]	8.3±3.4*
Calle-Verda	2018	TAVI	50	85.6±4.9	27 [54]	10 [20]	0	46 [92]	6 [12]	16 [32]	NR	NR	30 [60]	15.8±5.4*
Zierer	2009	MiAVR	30	82±4	19 [63]	NR	10 [33]	NR	7 [23]	7 [23]	7 [23]	NR	NR	35±9^#
Zierer	2009	TAVI	21	85±6	15 [71]	NR	7 [33]	NR	4 [19]	6 [29]	6 [29]	NR	NR	38±14^#
Tokarek	2015	MiAVR	44	67±5.0	20 [45]	NR	NR	NR	NR	NR	NR	NR	12 [27]	1.2±0.2*
Tokarek	2015	TAVI^a	39	80±2.5	14 [36]	NR	NR	NR	NR	NR	NR	NR	29 [74]	3.4±0.9*
COM
Paparella	2019	MIAVR	2,407	72±11	1121 [47]	42	567 [24]	1,713 [71]	201 [8]	482 [20]	NR	NR	NR	1.7±0.4*
Paparella	2019	TAVI	497	81±6	286 [58]	11	112 [23]	424 [85]	74 [15]	137 [28]	NR	NR	NR	3.3±0.9*

Continuous data presented as mean ± SD. ^a, data presented in both HS and RAT MiAVR cohorts. ^#, Logistic Euroscore; *, Euroscore II. RT, right anterior thoracotomy; HS, hemi sternotomy; COM, combined; NR, not reported; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary disease; HTN, hypertension; PVD, peripheral vascular disease; DM, diabetes mellitus; PAH, pulmonary hypertension; EF, left ventricular ejection fraction; NYHA, New York Heart Association; MiAVR, minimally invasive aortic valve replacement; TAVI, transcatheter aortic valve implantation, NR, not reported.